Vanadium in diabetes: 100 years from Phase 0 to Phase I
KH Thompson, C Orvig - Journal of inorganic biochemistry, 2006 - Elsevier
A little over one hundred years ago, a vanadium-containing compound was assessed
clinically for use in treatment of human diabetic patients. The results were somewhat …
clinically for use in treatment of human diabetic patients. The results were somewhat …
Boon and bane of metal ions in medicine
KH Thompson, C Orvig - Science, 2003 - science.org
In biological systems metal ions promote responses that range from deficiency to toxicity.
Some, such as iron and zinc, have a known optimal intake range for normal, healthy …
Some, such as iron and zinc, have a known optimal intake range for normal, healthy …
Medicinal inorganic chemistry approaches to passivation and removal of aberrant metal ions in disease
The field of medicinal inorganic chemistry has evolved with three conceptual aims: the
introduction of metal ions to the biological system, manipulation and redistribution of metal …
introduction of metal ions to the biological system, manipulation and redistribution of metal …
Design of targeting ligands in medicinal inorganic chemistry
This tutorial review will highlight recent advances in medicinal inorganic chemistry
pertaining to the use of multifunctional ligands for enhanced effect. Ligands that adequately …
pertaining to the use of multifunctional ligands for enhanced effect. Ligands that adequately …
Metal complexes in medicinal chemistry: new vistas and challenges in drug design
KH Thompson, C Orvig - Dalton transactions, 2006 - pubs.rsc.org
An overview is presented of selected metal-based pharmaceuticals, either diagnostic or
therapeutic, with emphasis on specific attributes and in vivo interactions of these compounds …
therapeutic, with emphasis on specific attributes and in vivo interactions of these compounds …
Synthesis and characterization of dual function vanadyl, gallium and indium curcumin complexes for medicinal applications
K Mohammadi, KH Thompson, BO Patrick… - Journal of inorganic …, 2005 - Elsevier
Novel bis [4-hydroxy-3-methoxyphenyl]-1, 6-heptadiene-3, 5-dione (curcumin) complexes
with the formula, ML3, where M is Ga (III) or In (III), or of the formula, ML2 where M is [VO] 2+ …
with the formula, ML3, where M is Ga (III) or In (III), or of the formula, ML2 where M is [VO] 2+ …
Therapeutic journey of 2, 4-thiazolidinediones as a versatile scaffold: An insight into structure activity relationship
Thiazolidinedione is an important heterocyclic ring system, a pharmacophore and a
privileged scaffold in medicinal chemistry; is a derivative of thiazolidine ring which came into …
privileged scaffold in medicinal chemistry; is a derivative of thiazolidine ring which came into …
[HTML][HTML] An overview on medicinal perspective of thiazolidine-2, 4-dione: A remarkable scaffold in the treatment of type 2 diabetes
G Bansal, PV Thanikachalam, RK Maurya… - Journal of advanced …, 2020 - Elsevier
Diabetes or diabetes mellitus is a complex or polygenic disorder, which is characterized by
increased levels of glucose (hyperglycemia) and deficiency in insulin secretion or resistance …
increased levels of glucose (hyperglycemia) and deficiency in insulin secretion or resistance …
Metal-based anti-diabetic drugs: advances and challenges
The current status and likely future directions of complexes of V (V/IV), Cr (III), Mo (VI), W (VI),
Zn (II), Cu (II), and Mn (III) as potential oral drugs against type 2 diabetes are reviewed. We …
Zn (II), Cu (II), and Mn (III) as potential oral drugs against type 2 diabetes are reviewed. We …
Toxicity of inorganic vanadium compounds
SK Ghosh, R Saha, B Saha - Research on Chemical Intermediates, 2015 - Springer
Vanadium causes a variety of toxic effects such as hematological and biochemical changes,
eg, hemolysis and decrease in erythrocyte count/hemoglobin level/hematocrit index …
eg, hemolysis and decrease in erythrocyte count/hemoglobin level/hematocrit index …